PMID: 9187429Jan 1, 1997Paper

Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France

Annals of Oncology : Official Journal of the European Society for Medical Oncology
C FoussardPhilippe Colombat

Abstract

The International Prognostic Index (IPI) is widely used to predict outcome of patients with aggressive lymphomas. Our goal was to assess the prognostic value of this index for low-grade lymphoma. One hundred eighty-two patients with disseminated (stage III or IV) low-grade lymphoma were enrolled in a prospective multicenter trial. According to the initial features, treatment either was started immediately or was deferred until indicated by disease progression. Patients received the same polychemotherapy regimen, given monthly for six cycles. They were assigned to one of four risk groups according to the number of presenting risk factors: low-risk (0 or 1), low-intermediate-risk (2), high-intermediate-risk (3), high-risk groups (4). Survival curves (Kaplan-Meier method) demonstrated a high significant difference for the four groups (log-rank: P < 0.0001). Median survival for the low-risk group has yet to be reached, while that for the three other groups are, respectively, 65, 34, and 12 months. In this study, the IPI has been found to be an important prognostic tool in low-grade lymphoma and may be used in the selection of appropriate therapeutic approaches for individual patients.

Citations

Jun 22, 2005·Current Treatment Options in Oncology·Christopher G Peterson, Brad S Kahl
Aug 12, 2006·Current Oncology Reports·Andrew J Davies
Sep 26, 2003·American Journal of Hematology·Michael B MøllerBjarne E Christensen
Jul 25, 2003·Cancer·Michael B MøllerNiels T Pedersen
Jun 9, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G PereaE Montserrat
Sep 11, 2010·The Korean Journal of Internal Medicine·Sung Yong Oh, Cheolwon Suh
Jul 20, 2017·Blood·Catherine ThieblemontEmanuele Zucca

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J W DenhamG V Hudson
Annals of Oncology : Official Journal of the European Society for Medical Oncology
G PereaEmili Montserrat
Leukemia & Lymphoma
Agustin AvilésJudith Huerta-Guzmán
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Y BastionBertrand Coiffier
© 2021 Meta ULC. All rights reserved